Technology | 2019.06.27
Eutropics Awarded MassVentures Funding to Commercialize Novel Predictive Cancer Diagnostics Technology
CAMBRIDGE, Mass., June 27, 2019 /PRNewswire/ -- Eutropics Pharmaceuticals Inc. (Eutropics) announced today that it has been awarded the highly competitive SBIR Targeted Technologies (START) program Stage III grant from MassVentures, a venture capital firm focused on identifying and...
For more information, please visit
https://www.prnewswire.com:443/news-rele[...]tics-technology-300876410.html
